PMID- 33171389 OWN - NLM STAT- MEDLINE DCOM- 20210514 LR - 20210514 IS - 1878-5883 (Electronic) IS - 0022-510X (Linking) VI - 419 DP - 2020 Dec 15 TI - Acute radiological features facilitate diagnosis and prognosis of anti-N-methyl-d-aspartate receptor (NMDAR) and anti-voltage-gated potassium channel (VGKC) encephalitis in adults. PG - 117216 LID - S0022-510X(20)30552-9 [pii] LID - 10.1016/j.jns.2020.117216 [doi] AB - BACKGROUND: Anti-N-methyl-d-aspartate receptor (NMDAR) and anti-voltage-gated potassium channel (VGKC) encephalitis are the commonest antibody-associated autoimmune encephalitides (AIE). Acute clinical features have been well-described, but data on the role of radiological findings in diagnosis and prognosis of AIE are limited. METHODS: Anti-NMDAR and anti-VGKC encephalitis patients from the National Neuroscience Institute were identified. We compared clinical and paraclinical features, at acute presentation and on follow-up between and within groups. RESULTS: Twenty-six anti-NMDAR and 11 anti-VGKC encephalitis patients were reviewed. At acute presentation, dysautonomia (57.7%) and impairment of consciousness (84.6%) occurred exclusively in anti-NMDAR encephalitis. Cerebrospinal fluid pleocytosis was more common in anti-NMDAR encephalitis (88.5% vs 20.0%, p = 0.003), while ictal electroencephalography abnormalities were more frequent in anti-VGKC encephalitis (11.5% vs 45.5%, p = 0.022). On acute imaging, leptomeningeal enhancement was seen only in anti-NMDAR encephalitis (37.5%), while hippocampal T2 hyperintensities supported the diagnosis of anti-VGKC encephalitis (63.6% vs 12.5%, p = 0.002). At follow-up (median 53.0 months, range 13.0-119.0), anti-NMDAR encephalitis patients had better modified Rankin scale scores (median 0.0 vs 3.0, p = 0.023). Relapses occurred equally in both groups. Anti-VGKC encephalitis patients with abnormal acute MRI were more likely to have poor outcomes compared to those with normal imaging (100% vs 25%, p = 0.008), whereas acute imaging features in anti-NMDAR encephalitis did not predict long-term outcomes. CONCLUSIONS: Acute MRI findings can aid in early diagnosis and prognostication in suspected AIE. Leptomeningeal enhancement in anti-NMDAR encephalitis and hippocampal lesions in anti-VGKC encephalitis, together with typical clinical features, may allow distinction between these antibody subtypes, and specific abnormal imaging features in anti-VGKC encephalitis may be used as a prognostic marker. CI - Copyright (c) 2020 Elsevier B.V. All rights reserved. FAU - Neo, Shermyn AU - Neo S AD - Department of Neurology, National Neuroscience Institute, Singapore. Electronic address: shermyn.neo.x.m@singhealth.com.sg. FAU - Yeo, Tianrong AU - Yeo T AD - Department of Neurology, National Neuroscience Institute, Singapore. FAU - Chen, Zhiyong AU - Chen Z AD - Department of Neurology, National Neuroscience Institute, Singapore. FAU - Ngiam, Nerice Heng Wen AU - Ngiam NHW AD - Department of Anaesthesiology, Singapore General Hospital, Singapore. FAU - Lim, Ethanyn Tyen-Xin AU - Lim ET AD - Department of Diagnostic Radiology, National University Health System, Singapore. FAU - Tan, Kevin AU - Tan K AD - Department of Neurology, National Neuroscience Institute, Singapore; Duke-NUS Medical School, Singapore. FAU - Lim, Tchoyoson Choie Cheio AU - Lim TCC AD - Duke-NUS Medical School, Singapore; Department of Neuroradiology, National Neuroscience Institute, Singapore. LA - eng PT - Journal Article DEP - 20201104 PL - Netherlands TA - J Neurol Sci JT - Journal of the neurological sciences JID - 0375403 RN - 0 (Autoantibodies) RN - 0 (Potassium Channels, Voltage-Gated) SB - IM MH - Adult MH - *Anti-N-Methyl-D-Aspartate Receptor Encephalitis/complications/diagnostic imaging MH - Autoantibodies MH - Humans MH - Neoplasm Recurrence, Local MH - *Potassium Channels, Voltage-Gated MH - Prognosis OTO - NOTNLM OT - Anti-NMDAR OT - Anti-VGKC OT - Autoimmune encephalitis OT - Magnetic resonance imaging OT - Outcomes EDAT- 2020/11/11 06:00 MHDA- 2021/05/15 06:00 CRDT- 2020/11/10 20:13 PHST- 2020/09/02 00:00 [received] PHST- 2020/10/27 00:00 [revised] PHST- 2020/11/01 00:00 [accepted] PHST- 2020/11/11 06:00 [pubmed] PHST- 2021/05/15 06:00 [medline] PHST- 2020/11/10 20:13 [entrez] AID - S0022-510X(20)30552-9 [pii] AID - 10.1016/j.jns.2020.117216 [doi] PST - ppublish SO - J Neurol Sci. 2020 Dec 15;419:117216. doi: 10.1016/j.jns.2020.117216. Epub 2020 Nov 4.